← All Picks
IQVWIN +27.1%

The largest pure-play CRO and healthcare-data business in the world trades at ~14x forward earnings, roughly a third below the medical-research peer median and its own multi-year a

IQVIA Holdings Inc. Common Stock · Healthcare
Published May 30, 2026
Exit History
Jul 24Closed 50% at $209.33+18.0%
Jul 29Closed 60% at $239.03+34.7%
Realized: +29.8%of original position (110% closed)
Alpha vs S&P 500:+29.3%
Time Horizon
12 weeks
Investment Thesis
This is a full institutional-grade investment thesis covering the company competitive position, near-term catalyst, valuation framework, key risks, and expected return profile. Subscribers unlock the complete analysis with specific price targets and stop-loss levels.
Unlock full thesis